HK regulator clarifies extraterritorial impact of OTC derivatives rules

Hong Kong's Chater House, home to the Securities and Futures Commission

Certain over-the-counter derivatives transactions, including those booked and cleared offshore through an appropriate jurisdiction – even when a Hong Kong entity is involved – are likely to receive reporting and clearing exemptions from tough new rules being drafted to become law in Hong Kong, according to Rico Leung, senior director at Hong Kong's Securities and Futures Commission (SFC).

Leung sought to clarify the scope of the new regulatory regime for the OTC derivatives markets in Hong Kong

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here:

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: